Lanean...
Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
BACKGROUND AND AIM: It is unclear how adding an anti‐tumor necrosis factor alpha agent to immunomodulator (IM) treatment, as a step‐up strategy, affects long‐term outcomes in ulcerative colitis. This retrospective study investigated persistence associated with biologic anti‐tumor necrosis factor alp...
Gorde:
| Argitaratua izan da: | J Gastroenterol Hepatol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027773/ https://ncbi.nlm.nih.gov/pubmed/31397010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.14825 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|